Contains Nonbinding Recommendations Guidance for Industry and FDA Staff: Early Development Considerations for Innovative Combination Products For questions regarding this document, contact: Patricia Y. Love, MD, Office of Combination Products, at 301-427-1934. U.S. Department of Health and Human Services Food and Drug Administration Office of the Commissioner Office of Combination Products September 2006
This preview has intentionally blurred sections.
Sign up to view the full version.